• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逆转录酶-聚合酶链反应筛查对乳腺癌患者腋窝淋巴结微转移疾病的疗效

Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients.

作者信息

Lockett M A, Metcalf J S, Baron P L, O'Brien P H, Elliott B M, Robison J G, Cole D J

机构信息

Department of Surgery (Section of Surgical Oncology), Hollings Cancer Center, Medical University of South Carolina, Charleston 29425, USA.

出版信息

Am Surg. 1998 Jun;64(6):539-43; discussion 543-4.

PMID:9619175
Abstract

Pathologic examination of axillary lymph nodes (ALNs) may miss micrometastases in 30 per cent of breast cancer patients. We have developed a multimarker reverse transcriptase-polymerase chain reaction (RT-PCR)-based screening method that detects histopathologically positive ALNs with a 5 per cent false-negative rate. The purpose of this study was to compare this RT-PCR methodology with histopathology with regard to sensitivity and cost. Pathologically negative ALNs from 35 breast cancer patients were re-evaluated by a single pathologist in a blinded fashion using serial sectioning with immunohistochemical staining. Histopathologic results were then compared with those of RT-PCR. Cost analysis was performed based on standard charges for these methods. RT-PCR identified micrometastases in 14 of 35 pathologically negative nodes. Serial sectioning and immunohistochemical staining identified micrometastases in two cases, with RT-PCR positive for one of these. The charge per specimen for performing routine histopathologic examination was $380, serial sectioning and immunohistochemical staining $787, and RT-PCR $125. RT-PCR appears to be more sensitive at detecting ALN micrometastasis than histopathologic examination even with serial sectioning and immunohistochemical staining. If micrometastatic breast cancer detected by RT-PCR proves to be clinically relevant, it could be a more effective screening methodology with significant cost savings as compared to currently available pathologic examinations.

摘要

腋窝淋巴结(ALNs)的病理检查可能会使30%的乳腺癌患者漏诊微转移。我们开发了一种基于多标记逆转录酶 - 聚合酶链反应(RT-PCR)的筛查方法,该方法检测组织病理学检查呈阳性的ALNs时假阴性率为5%。本研究的目的是比较这种RT-PCR方法与组织病理学在敏感性和成本方面的差异。对35例乳腺癌患者病理检查为阴性的ALNs,由一名病理学家采用连续切片免疫组化染色的方法进行盲法重新评估。然后将组织病理学结果与RT-PCR结果进行比较。基于这些方法的标准收费进行成本分析。RT-PCR在35个病理检查阴性的淋巴结中检测到14个存在微转移。连续切片免疫组化染色检测到2例存在微转移,其中1例RT-PCR呈阳性。进行常规组织病理学检查每个标本收费380美元,连续切片免疫组化染色收费787美元,RT-PCR收费125美元。即使采用连续切片免疫组化染色,RT-PCR在检测ALN微转移方面似乎比组织病理学检查更敏感。如果RT-PCR检测到的微转移乳腺癌被证明具有临床相关性,那么与目前可用的病理检查相比,它可能是一种更有效的筛查方法,且能显著节省成本。

相似文献

1
Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients.逆转录酶-聚合酶链反应筛查对乳腺癌患者腋窝淋巴结微转移疾病的疗效
Am Surg. 1998 Jun;64(6):539-43; discussion 543-4.
2
Quantitative molecular diagnosis of axillary drainage fluid for prediction of locoregional failure in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.腋窝引流液的定量分子诊断用于预测保乳术后腋窝淋巴结1-3个阳性且未接受辅助放疗患者的局部区域复发情况
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):505-11. doi: 10.1016/j.ijrobp.2005.07.984. Epub 2005 Oct 26.
3
Detection of micrometastases in lymph nodes from patients with breast cancer.乳腺癌患者淋巴结中微转移灶的检测。
Br J Surg. 2002 Jan;89(1):86-9. doi: 10.1046/j.0007-1323.2001.01970.x.
4
Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.通过逆转录聚合酶链反应检测腋窝淋巴结中的乳腺癌微转移。MUC1 mRNA与角蛋白19 mRNA扩增的比较。
Am J Pathol. 1996 Feb;148(2):649-56.
5
Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.乳腺癌腋窝前哨淋巴结中的转录-逆转录协同反应与微小残留病
Eur J Surg Oncol. 2007 May;33(4):430-4. doi: 10.1016/j.ejso.2006.09.038. Epub 2006 Nov 13.
6
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.用于检测乳腺癌患者前哨淋巴结微小残留病的多标志物逆转录聚合酶链反应检测法
Br J Cancer. 2006 Mar 13;94(5):681-5. doi: 10.1038/sj.bjc.6602992.
7
Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.通过角蛋白19信使核糖核酸逆转录聚合酶链反应检测到的伴有隐匿性淋巴结转移的乳腺癌的组织学特征
Cancer. 1996 Sep 15;78(6):1235-40. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1235::AID-CNCR10>3.0.CO;2-1.
8
Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.前哨淋巴结活检及细胞角蛋白染色用于478例乳腺癌患者的准确分期
Am Surg. 1999 Jun;65(6):500-5; discussion 505-6.
9
The clinical significance of axillary lymph node micrometastases in breast cancer.乳腺癌腋窝淋巴结微转移的临床意义。
Eur J Surg Oncol. 2004 Oct;30(8):807-16. doi: 10.1016/j.ejso.2004.06.020.
10
[The detection of breast carcinoma micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction].[应用逆转录聚合酶链反应检测腋窝淋巴结中的乳腺癌微转移灶]
Zhonghua Wai Ke Za Zhi. 1998 Jul;36(7):430-2.

引用本文的文献

1
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.组织病理学阴性腋窝淋巴结中微转移乳腺癌的分子检测与传统预后预测指标相关:一项前瞻性多机构队列研究的中期分析
Ann Surg. 2004 Jun;239(6):828-37; discussion 837-40. doi: 10.1097/01.sla.0000128687.59439.d6.
2
Quantitative evaluation of metastases in axillary lymph nodes of breast cancer.乳腺癌腋窝淋巴结转移的定量评估。
Br J Cancer. 2003 Nov 3;89(9):1750-6. doi: 10.1038/sj.bjc.6601248.
3
The limited incorporation of economic analyses in clinical practice guidelines.
临床实践指南中经济分析的应用有限。
J Gen Intern Med. 2002 Mar;17(3):210-20. doi: 10.1046/j.1525-1497.2002.10522.x.
4
Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases.人胃肠道癌原位移植模型及微转移检测
World J Gastroenterol. 2001 Jun;7(3):381-6. doi: 10.3748/wjg.v7.i3.381.
5
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.催乳素诱导蛋白(PIP)作为人类乳腺癌微转移标志物的潜在作用。
Br J Cancer. 1999 Nov;81(6):1002-8. doi: 10.1038/sj.bjc.6690799.